Prenylamine

CHEMBL24072 Phase 4 승인됨 Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

329.5 g/mol

LogP

6.0

Phase

4

Prenylamine is a calcium channel antagonist and monoamine depleting agent that was used for the treatment of angina pectoris by reducing myocardial oxygen demand through vasodilation and negative inotropic effects. It was withdrawn from many markets due to its propensity to cause QT prolongation and potentially fatal ventricular arrhythmias, particularly torsades de pointes.

분자량

329.5000 g/mol

LogP

6.00

TPSA

12.00 Å²

리핀스키 5의 법칙

통과

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D 구조

SVG PNG

Cite this structure

Embed this structure

SMILES

CC(Cc1ccccc1)NCCC(c1ccccc1)c1ccccc1

InChI

InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3

Molecular Formula

C24H27N

HBD / HBA

1 / 1

회전 가능 결합

8

무거운 원자

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

자주 묻는 질문

Prenylamine is a calcium channel antagonist and monoamine depleting agent that was used for the treatment of angina pectoris by reducing myocardial oxygen demand through vasodilation and negative inotropic effects. It was withdrawn from many markets due to its propensity to cause QT prolongation and potentially fatal ventricular arrhythmias, particularly torsades de pointes.

Yes, Prenylamine is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL24072. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 9801. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

환자 친화적 정보를 찾고 계신가요?

Prenylamine PillFYI에서

구조

핵심 데이터

분자식: C24H27N

외부 링크

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

의학적 면책조항

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.